Results Further Support The Benefits Of TYSABRI For Multiple Sclerosis Patients | Psydir News
Links shared publicly online about this topic.
- 1,750total visits
Results Further Support The Benefits Of TYSABRI For Multiple Sclerosis Patients | Psydir News
Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) have announced six-month results of an ongoing, one-year longitudinal, observational, patient-reported outcomes study showing multiple sclerosis (MS) patients taking TYSABRI (natalizumab) experienced an improvement in both their physical function and psychological well-being. Findings from the study, which was performed in conjunct...
View full resource at news.psydir.com
Tags: Multiple Sclerosis, Healthy Living, Tysabri, Biogen Idec, Elan Corp., Psychology
Most Recently Shared on September 14, 2009 at 12:32 pm By:
Results Further Support The Benefits Of TYSABRI For Multiple Sclerosis Patients http://ow.ly/15OWal
Results Further Support The Benefits Of TYSABRI For Multiple Sclerosis Patients
medicalnewstoday.com — “Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) have announced six-month results of an ongoing, one-year longitudinal, observational, patient-reported outcomes study showing multi” View full resource at medicalnewstoday.com
Most Recently Shared on September 14, 2009 at 10:12 am By:
psychiatryrounds Psychiatry and Support
Results Further Support The Benefits Of TYSABRI For Multiple Sclerosis Patients: Biogen Idec (NASDAQ: BIIB) and .. http://bit.ly/jkuoc
Advertisement
